Skip to main content
Screener/Healthcare/Biotechnology

ADMA — ADMA Biologics, Inc.

NASDAQ
$11.38-0.36 (-3.11%)
Mid CapUnder $20HealthcareHigh ROEMost Profitable
$7.21
$20.40
$11.37
$11.90
EPS (TTM)$0.68
P/E Ratio16.74
Dividend Yield—
Market Cap$2.39B
Volume1.40M
Prev Close$11.75
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$114.5M$45.3M$0.1970.5%39.6%
Q4 '25$139.2M$49.4M$0.2063.8%35.5%
Q3 '25$134.2M$36.4M$0.1556.3%27.1%
Q2 '25$122.0M$34.2M$0.1455.1%28.1%
Q1 '25$114.8M$26.9M$0.1153.2%23.4%
Q4 '24$117.5M$111.9M$0.4653.9%95.2%
Q3 '24$119.8M$35.9M$0.1549.8%30.0%
Q2 '24$107.2M$32.1M$0.1353.6%29.9%
Get Your Daily Market Recap